CVS Health moves to dismantle $117bn healthcare empire

CVS Health is making a significant move by considering the spin-off of its drugstore business amid increasing political pressure on pharmacy benefit managers and health insurers. This strategic shift comes as regulators and lawmakers are scrutinizing the healthcare industry for practices that may inflate drug prices and increase costs for consumers. By potentially dismantling its $117bn healthcare empire, CVS aims to address these concerns and reshape its business model to better align with changing regulatory landscapes and market expectations.